Amgen Inc. buy phonebroker
Start price
26.03.16
/
50%
€135.16
Target price
17.06.16
€171.27
Performance (%)
0.71%
End price
17.06.16
€135.22
Summary
This prediction ended on 17.06.16 with a price of €135.22. The BUY prediction by phonebroker for Amgen Inc. closed nearly unchanged. phonebroker has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amgen Inc. | -0.281% | -0.281% | 20.096% | 43.989% |
| iShares Core DAX® | 0.878% | 1.051% | 7.091% | 54.452% |
| iShares Nasdaq 100 | 0.753% | 4.664% | 41.848% | 95.491% |
| iShares Nikkei 225® | 5.519% | 15.411% | 73.760% | 85.818% |
| iShares S&P 500 | 0.236% | 1.683% | 27.527% | 69.017% |
Comments by phonebroker for this prediction
In the thread Amgen Inc. diskutieren
phonebroker stimmt dem Sentiment von 'Buy' zu
phonebroker stimmt am 26.03.2016 dem Buy-Gesamtsentiment mit dem Kursziel 189.88$ zu. Der BioTech-Sektor ist in letzter Zeit nicht so gut gelaufen. Das könnte sich in nächster Zeit wieder ändern.
(Stop Loss Kurs erreicht)